Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02830776Phase 1Completed
Phase 1, open-label, single-arm trial of bimatoprost in dermatochalasis, sponsored by Tulane University. Primary endpoint: Graded Change in Dermatochalasis at 12 weeks. Started Nov 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02830776.